GRN and invasive ductal breast carcinoma: In pathological studies of 203 human breast cancer biopsies, GP88 was expressed in 80% of invasive ductal carcinomas in correlation with parameters of poor prognosis [31] whereas it was negative in benign lesion and normal mammary epithelial tissues.